Tobramycin Solution
Product Images NDC 76204-029

21 FDA label images from Ritedose Pharmaceuticals, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Tobramycin (NDC 76204-029). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ritedose Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structural Formula For Tobramycin (Tob00 0015 01)

Structural Formula For Tobramycin (Tob00 0015 01)
Chemical structure diagram of the active ingredient Tobramycin, showing its molecular framework with labeled functional groups and bond connections typical for an aminoglycoside antibiotic.*
FDA Label Image

Figure 1 (Figure 1)

Figure 1 (Figure 1)
A line graph titled 'Relative Change From Baseline in FEV1 % Predicted' showing average relative change over 24 weeks. It compares Tobramycin Inhalation Solution versus placebo in two studies, with Tobramycin showing sustained positive change in FEV1 % predicted, while placebo groups fluctuate near zero or negative change. The timeline includes drug administration periods marked at weeks 0, 8, and 16.*
FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)
A line graph titled 'Absolute Change From Baseline in Log10 CFUs' shows the average change of Log10 CFUs over 24 weeks. It compares two studies of Tobramycin Inhalation Solution versus placebo, indicating changes at multiple time points with labeled periods of drug administration.*
FDA Label Image

Figure A (Tob00 0015 04)

Figure A (Tob00 0015 04)
An instructional illustration showing components of a respiratory inhalation setup including an air compressor, nebulizer cup, inspiratory valve cap, ampule, mouthpiece, clean paper or cloth towels, and tubing arranged on a surface with a carrying case in the background.*
FDA Label Image

Figure B (Tob00 0015 05)

Figure B (Tob00 0015 05)
An instructional illustration showing two hands holding individual ampules of Tobramycin inhalation solution 300 mg/5 mL. The image demonstrates the correct method to snap open the ampules by bending the top portion backward to access the solution.*
FDA Label Image

Figure C (Tob00 0015 06)

Figure C (Tob00 0015 06)
An illustrated diagram of a single-use vial of Tobramycin inhalation solution, USP, showing the location of the expiration date on the vial's label. The vial contains a respiratory inhalation solution with a strength of 300 mg/5 mL, produced by Ritedose Pharmaceuticals, LLC.*
FDA Label Image

Figure D (Tob00 0015 07)

Figure D (Tob00 0015 07)
An instructional illustration showing the assembly of a Tobramycin inhalation solution nebulizer. The diagram labels components including the nebulizer top, nebulizer cup, mouthpiece, inspiratory valve cap, and tubing, demonstrating how these parts connect for respiratory administration.*
FDA Label Image

Figure E (Tob00 0015 08)

Figure E (Tob00 0015 08)
An instructional diagram showing how to insert the nebulizer insert into the nebulizer cup for a respiratory inhalation solution. The image illustrates the orientation with a labeled 'Top' arrow and hands positioning the parts during assembly.*
FDA Label Image

Figure F (Tob00 0015 09)

Figure F (Tob00 0015 09)
An instructional illustration showing the assembly of a nebulizer cup with labeled parts. The diagram includes a top piece and the main nebulizer cup, positioned on a clean surface labeled as paper or cloth towels, indicating setup for respiratory inhalation solution administration.*
FDA Label Image

Figure G (Tob00 0015 10)

Figure G (Tob00 0015 10)
An instructional illustration showing a hand placing or removing a product tray labeled 'Tobramycin' from a device, likely depicting the step of loading or handling the Tobramycin inhalation solution device.*
FDA Label Image

Figure H (Tob00 0015 11)

Figure H (Tob00 0015 11)
An instructional illustration showing a hand plugging a two-prong electrical plug into a standard two-outlet wall socket, with a directional arrow indicating the motion of insertion.*
FDA Label Image

Figure I (Tob00 0015 12)

Figure I (Tob00 0015 12)
An instructional diagram demonstrating the opening of a Tobramycin inhalation solution unit dose vial. The image shows hands holding the vial with an arrow indicating the direction to tear off the bottom tab for opening the unit dose container.*
FDA Label Image

Figure J (Tob00 0015 13)

Figure J (Tob00 0015 13)
An instructional illustration showing a hand holding a syringe above a medical device, likely demonstrating how to load or prepare an inhalation solution for respiratory administration.*
FDA Label Image

Figure K (Tob00 0015 14)

Figure K (Tob00 0015 14)
An instructional illustration showing the assembly of a nebulizer used for inhalation medication. It depicts components including the nebulizer top, stem, semi-circle, nebulizer outlet, and nebulizer cup, demonstrating how the parts fit together.*
FDA Label Image

Figure L (Tob00 0015 15)

Figure L (Tob00 0015 15)
An instructional diagram showing the components of a nebulizer for respiratory inhalation solution. It depicts a mouthpiece, nebulizer outlet, and nebulizer cup, illustrating how they connect for use with a solution such as Tobramycin inhalation. The image aids in understanding assembly and usage.*
FDA Label Image

Figure M (Tob00 0015 16)

Figure M (Tob00 0015 16)
An instructional diagram showing the assembly of a respiratory inhalation device for Tobramycin solution. It highlights the placement of the inspiratory valve cap onto the main body of the device, used for administering the 300 mg/5 mL Tobramycin inhalation solution by Ritedose Pharmaceuticals, LLC.*
FDA Label Image

Figure N (Tob00 0015 17)

Figure N (Tob00 0015 17)
An instructional diagram showing the assembly of a respiratory inhalation device. It features a solution container with a handle and an air intake, positioned above a mouthpiece, with arrows indicating the connection direction.*
FDA Label Image

Figure O (Tob00 0015 18)

Figure O (Tob00 0015 18)
An instructional line drawing showing a hand adjusting or positioning a portion of a device labeled "Pulmo-Aide." The image likely illustrates a step in using a respiratory inhalation device.*
FDA Label Image

Figure P (Tob00 0015 19)

Figure P (Tob00 0015 19)
An instructional diagram showing a handheld nebulizer device emitting aerosol vapor from its mouthpiece. The device includes a mouthpiece, a cup-like chamber, and a handle with a connected cord, representing a respiratory inhalation solution delivery system.*
FDA Label Image

Figure Q (Tob00 0015 20)

Figure Q (Tob00 0015 20)
An instructional illustration showing a person using a respiratory inhalation device with a nose clip applied, demonstrating proper use for inhalation therapy.*
FDA Label Image

Tobramycin Inhalation Solution Carton (56 Single-dose Ampules)

Tobramycin Inhalation Solution Carton (56 Single-dose Ampules)
Tobramycin Inhalation Solution, USP 300 mg/5 mL ampules packaging label. The box contains 56 single-dose ampules for respiratory inhalation, with instructions to store in a refrigerator. Manufactured by Ritedose Pharmaceuticals, LLC, the label highlights it is preservative-free and for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.